You searched for "radiation"
Johnson & Johnson announces lead vaccine candidate for COVID-19
Johnson & Johnson has announced the selection of a lead COVID-19 vaccine candidate and the rapid scaling of its manufacturing capacity with the goal of providing global supply of more than one billion doses.Oban blind man could voice Lidl's new self-checkouts
An Oban man who lost his sight over a decade ago is one of ten finalists in Lidl’s nationwide search for the voice of its new Scottish self-checkouts. Alan MacDonald (46) is in the running to become the friendly voice...Lockdown and eye health – a case of accommodative spasm
A 25-year-old male presented to the eye casualty with a one-day history of sudden onset worsening vision. More specifically, he noted his vision was more blurred than usual and this was more exaggerated for near-work than for distance-work. He was...ABDO responds to GOC research
New research published by the General Optical Council (GOC) shows an increase in public satisfaction in eyecare services.Sight loss befriender offers 'life changing' support to Freda
Sight Scotland, Scotland’s largest sight loss organisation, is appealing for more volunteer befrienders to help battle loneliness and isolation.
Evisceration in India: demographic and clinical trends from a large multicentre cohort study
In this multicentre cohort study, the authors investigated a total of 2071 patients who underwent evisceration with primary implant placement over a six-year period at four tertiary eyecare centres in India. Out of 1,345,480 new ophthalmic presentations during the study...Transferring imaging from primary to secondary care (part 2)
Transferring clinical imaging from high street optometrists to secondary care is an increasingly requested option, especially in the context of the COVID-19 pandemic. A wide variety of solutions exist to allow this, each with their own merits and shortcomings. In...Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease
Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...
